Jane Street’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRO
Jane Street's SPRO Position: Q3 2026 in Review
Jane Street reduced its Spero Therapeutics (SPRO) stake by 87% in Q3 2026, selling an estimated $187K and leaving 20,185 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #11226.
Jane Street first reported a position in SPRO in Q1 2021 and has held it in 9 quarters since. The position peaked at $369K in Q4 2025. 61 funds tracked by Wall St. Rank hold SPRO as of Q3 2026.
- Jane Street held 20,185 shares of Spero Therapeutics worth $24.4K as of Q3 2026.
- Jane Street sold 137,912 Spero Therapeutics shares in Q3 2026, an estimated $187K.
- Spero Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11226 holding.
- Jane Street first reported a position in Spero Therapeutics in Q1 2021 and has held it in 9 quarters since.
- Jane Street's Spero Therapeutics position peaked at $369K in Q4 2025.
- 61 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.